In a recent study on the myeloimmune microenvironment of AML, researchers have found that FOXC1 expression is significantly inhibited in AML marrow neutrophils and monocytes [40], but its expression in lymphocytes, particularly T cells, has not been reported yet. The gene discussed is FOXC1; the disease is acute myeloid leukemia.